Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma

Immune checkpoint inhibitors have changed the landscape of classic cancer treatment. However, their use is associated with the emergence of new adverse events. An elderly man with rheumatoid arthritis was started on pembrolizumab for newly diagnosed advanced lung cancer. He subsequently developed he...

Descripción completa

Detalles Bibliográficos
Autores principales: Akagi, Yu, Awano, Nobuyasu, Inomata, Minoru, Kuse, Naoyuki, Tone, Mari, Yoshimura, Hanako, Jo, Tatsunori, Takada, Kohei, Kumasaka, Toshio, Izumo, Takehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205536/
https://www.ncbi.nlm.nih.gov/pubmed/32009093
http://dx.doi.org/10.2169/internalmedicine.3889-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205536/
https://www.ncbi.nlm.nih.gov/pubmed/32009093
http://dx.doi.org/10.2169/internalmedicine.3889-19

Ejemplares similares